Terms: = Breast cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614 AND Prognosis
5 results:
1. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of kdm5a and regulation of H3K4me3 demethylation.
Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
[TBL] [Abstract] [Full Text] [Related]
2. Expression and prognostic values of ARID family members in breast cancer.
Zhang J; Hou S; You Z; Li G; Xu S; Li X; Zhang X; Lei B; Pang D
Aging (Albany NY); 2021 Feb; 13(4):5621-5637. PubMed ID: 33592583
[TBL] [Abstract] [Full Text] [Related]
3. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.
Hinohara K; Wu HJ; Vigneau S; McDonald TO; Igarashi KJ; Yamamoto KN; Madsen T; Fassl A; Egri SB; Papanastasiou M; Ding L; Peluffo G; Cohen O; Kales SC; Lal-Nag M; Rai G; Maloney DJ; Jadhav A; Simeonov A; Wagle N; Brown M; Meissner A; Sicinski P; Jaffe JD; Jeselsohn R; Gimelbrant AA; Michor F; Polyak K
Cancer Cell; 2018 Dec; 34(6):939-953.e9. PubMed ID: 30472020
[TBL] [Abstract] [Full Text] [Related]
4. Genome-Wide Methylation Analysis Identifies NOX4 and kdm5a as Key Regulators in Inhibiting breast cancer Cell Proliferation by Ginsenoside Rg3.
Ham J; Lee S; Lee H; Jeong D; Park S; Kim SJ
Am J Chin Med; 2018; 46(6):1333-1355. PubMed ID: 30149757
[TBL] [Abstract] [Full Text] [Related]
5. Histone lysine demethylases in breast cancer.
Paolicchi E; Crea F; Farrar WL; Green JE; Danesi R
Crit Rev Oncol Hematol; 2013 May; 86(2):97-103. PubMed ID: 23266085
[TBL] [Abstract] [Full Text] [Related]
